Aviva’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45,870
Closed -$1.52M 1002
2023
Q3
$1.52M Hold
45,870
0.01% 656
2023
Q2
$1.41M Hold
45,870
0.01% 752
2023
Q1
$1.26M Sell
45,870
-103,242
-69% -$2.87M 0.01% 829
2022
Q4
$4.17M Hold
149,112
0.02% 602
2022
Q3
$4.4M Hold
149,112
0.03% 596
2022
Q2
$4.2M Hold
149,112
0.02% 612
2022
Q1
$4.65M Hold
149,112
0.02% 605
2021
Q4
$4.41M Hold
149,112
0.02% 619
2021
Q3
$4.47M Hold
149,112
0.02% 605
2021
Q2
$5.41M Sell
149,112
-47,172
-24% -$1.75M 0.02% 576
2021
Q1
$7.19M Buy
+196,284
New +$7.22M 0.04% 426

Other funds holding OHI

Aviva's OHI Position: Q4 2023 in Review

Aviva sold out of Omega Healthcare (OHI) in Q4 2023, closing a stake of 45,870 shares — an estimated $1.52M sold.

Aviva first reported a position in OHI in Q1 2021 and held it in 11 quarters. The position peaked at $7.19M in Q1 2021. 528 funds tracked by Wall St. Rank hold OHI as of Q4 2023.

  • Aviva reported no remaining Omega Healthcare position as of Q4 2023 after selling out during the quarter.
  • Aviva sold 45,870 Omega Healthcare shares in Q4 2023, an estimated $1.52M.
  • Aviva first reported a position in Omega Healthcare in Q1 2021 and held it in 11 quarters.
  • Aviva's Omega Healthcare position peaked at $7.19M in Q1 2021.
  • 528 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2023.

Based on Aviva's 13F filing for Q4 2023, filed 9 Feb 2024.